In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Puja BoseDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0003-4107-1430 Gourab HalderDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0002-3873-3280 Pratanu KayetDivision of Bioinformatics, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
Goutam ChowdhuryDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0003-1830-1920 Surajit BasakDivision of Bioinformatics, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
Deboleena RoyDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
Daisuke ImamuraCollaborative Research Centre of Okayama University for Infectious Diseases at ICMR-NIRBI, Kolkata, India.
Masatomo MoritaDepartment of Bacteriology I, National Institute of Infectious Diseases, Shinjuku City, Tokyo, Japan.ORCID 0000-0002-2850-0053 Thandavarayan RamamurthyDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0001-7999-5036 Hemanta KoleyDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.
Santasabuj DasDivision of Clinical Medicine, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0003-0745-469X Asish Kumar MukhopadhyayDivision of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Kolkata, India.ORCID 0000-0002-5638-4520 Funding
Japan Agency for Medical Research and Development JP21wm0125004Japan Agency for Medical Research and Development JP23wm0225021
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
beta-LactamasesDrug Resistance, Multiple, BacterialDysentery, BacillaryShigellaAnti-Bacterial AgentsAzithromycinBacterial ProteinsCeftriaxoneCiprofloxacinHumansIndiaMicrobial Sensitivity TestsPandemicsPhylogenyPlasmidsSARS-CoV-2Anti-Bacterial AgentsAzithromycinBacterial Proteinsbeta-LactamasesCeftriaxoneCiprofloxacinThird Generation CephalosporinsAMRCTX-MdysenteryPFGEplasmidShigella spp.transconjugantsWGSXDR
Identifiers
PMID42496106
PMCPMC13532320
What OpenQuestion holds
Textmetadata
Read underepoch 390